Overview

A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients

Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
Participant gender:
Summary
This 6 month long study will assess an investigational medication for patients on dialysis with secondary hyperparathyroidism. The study will look at the effects on parathyroid hormone, calcium and phosphorus levels.
Phase:
Phase 3
Details
Lead Sponsor:
Amgen
Treatments:
Cinacalcet
Cinacalcet Hydrochloride